Palabras clave
COVID-19
Ansiedad
Depresión
Cuestionario de Salud del Paciente
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Evaluar la calidad de vida relacionada con la salud (CVRS), la calidad de vida (CV) y los síntomas de ansiedad y depresión al año del alta hospitalaria en sobrevivientes de COVID-19. Métodos: Se trata de un estudio cuyo diseño es transversal, descriptivo y exploratorio. La muestra estuvo compuesta por 41 pacientes ingresados en un hospital público del Estado de Ceará para el tratamiento de la COVID-19 de marzo a diciembre de 2020. Se aplicó el instrumento WHOQOL-bref para evaluar la CV; para la CVRS el instrumento SF-36 Item Short-Form Health Survey y para investigar signos y síntomas de ansiedad y depresión el HADS. La recogida de datos se realizó mediante llamada telefónica un año después del alta hospitalaria. Resultados: El estudio mostró que las pacientes hospitalizadas por COVID-19 se enfrentaron a una CdV, CVRS y síntomas de ansiedad y depresión más comprometidos hasta un año después del alta hospitalaria en comparación con los hombres. Conclusión: este estudio mostró que las personas que fueron hospitalizadas como consecuencia de la COVID-19 enfrentan deterioro de la CV, CVRS y síntomas de ansiedad y depresión hasta un año después del alta hospitalaria, siendo las mujeres con mayor deterioro.
Referencias
AKISKAL KK e AKISKAL HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord, 2005; 85(1-2): 231-9.
ALMEIRDA-BRASIL CC, et al. Qualidade de vida e características associadas: Aplicação do WHOQOL-BREF no contexto da Atenção Primária à Saúde. Ciência e Saúde Coletiva, 2017; 22(5): 1705–1716.
BAI F, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin MicrobiolInfect, 2022; 28(4): 611.e9-611.e16.
BOTEGA NJ, et al. Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. J Bras Psiq, 1998; 47: 285-289.
CARFÌ A, et al. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605.
CARVALHO TM, et al. Índice de vulnerabilidade à COVID-19: uma aplicação para a cidade de Fortaleza (CE), Brasil. Engenharia Sanitaria e Ambiental, 2021; 26(4): 731–739.
CHAIX B, et al. Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations. General psychiatry, 2020; 33(6).
CICONELLI RM, et al. Tradução para a língua portuguesa e validação do questionáriogenérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol, 1999; 39: 143-50.
DIMITROVA BC, et al. Quality of life. London: BMJ Books, 2003. 133 pp. ISBN 0-7279-1544-4. European journal of public health, 2005; 15(6): 668-668.
FINE PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med, 2011; 12(7): 996-1004.
FLECK M et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida" WHOQOL-bref". Revista de saúde pública, 2000; 34: 178-183.
FLOR LS, et al. Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021. Lancet, 2022; 399(10344): 2381-2397.
FRAMEWORK I. Conceptual. The MOS 36-item short-form health survey (SF-36). Med Care, 1992; 30, (6): 473-83.
HARAPAN BN e YOO HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol, 2021; 268(9): 3059-3071.
HARRIS PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform, 2019; 95: 103208.
HEESAKKERS H, et al. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA, 2022; 327(6): 559-565.
HERRIDGE MS, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive care medicine, 2016; 42 (5): 725-738.
KHOJA O, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J Pain Res, 2022; 17(15): 1729-1748.
KOOHI F, et al. Quality of Life among General Populations of Different Countries in the Past 10 Years, with a Focus on Human Development Index: A Systematic Review and Meta-analysis. Iran J Public Health, 2017; 46(1): 12-22.
NALBANDIAN A, et al. Post-acute COVID-19 syndrome. Nature medicine, 2021; 27(4): 601-615.
NEPOMUCENO E, et al. Comparação de instrumentos para avaliar fadiga em pacientes com insuficiência cardíaca. Revista Brasileira de Enfermagem, 2018; 71: 2404-2410.
PIEH C, et al. The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria. J Psychosom Res. 2020; 136: 110186.
PIQUERO AR, et al. Domestic violence during the COVID-19 pandemic-Evidence from a systematic review and meta-analysis. Journal of criminal justice, 2021; 74: 101806.
PODESTÁ MHMC, et al. Qualidade de vida dos usuários da Atenção Primária à Saúde: perfil e fatores que interferem. RUVRD 2013; 11(2): 316-326.
REIGADA CL de L e SMIDERLE C de ASL. Atenção à saúde da mulher durante a pandemia COVID-19: orientações para o trabalho na APS. Rev Bras Med Fam Comunidade, 2021; 16(43): 2535.
RODRIGUES MVC. Qualidade de vida no trabalho: evolução e análise num nível gerencial. 8ª ed. Petrópolis: Vozes, 2001.
RUDROFF T, et al. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci, 2020; 10(12): 1012.
SHAH W, et al. UK guidelines for managing long-term effects of COVID-19. Lancet (London, England), 2021; 397(10286): 1706.
SIVAN M, et al. Post‐COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross‐sectional evaluation from a community COVID rehabilitation service. Journal of medical virology, 2022; 94(4): 1419-1427.
STIVAL MM, et al. Fatores associados à qualidade de vida de idosos que frequentam uma unidade de saúde do Distrito Federal. Revista Brasileira de Geriatria e Gerontologia, 2014; 17(2): 395–405.
WANG J, et al. Gender difference in neural response to psychological stress. Soc Cogn Affect Neurosci, 2007; 2(3): 227-39.
WARE JEJ e SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical care, 1992; 30(6): 473–483.
WOMEN UN e SNYDER D. COVID-19 and the care economy: Immediate action and structural transformation for a gender-responsive recovery. Policy Brief, 2020; 16(16).
XIE Y, et al. Risks of mental health outcomes in people with covid-19: cohort study. BMJ, 2022; 16(376): e068993.
ZIEGLER CGK, et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell, 2020; 181(5): 1016-1035.e19.
ZIGMONDI A S e SNALTH RP. The Hospital Anxiety and Depression Scale. Acta psychiatr. scand., 2014; 64(5): 361-370.